Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zenas BioPharma, Inc. | 1,173,395 | reported | 09 Oct 2025 | tx 9+3,175,459−18,880,967 |
| TREVENA INC | 13,700 | reported | 13 Jun 2024 | tx 12+372,091 |
| TriVascular Technologies, Inc. | 10,000 | reported | 22 May 2015 | tx 1+10,000 |
| NOVACEA INC | 0 | reported | 30 Oct 2014 | tx 11+33,400−3,615 |
| HYPERION THERAPEUTICS INC | 0 | reported | 07 May 2015 | tx 10+17,356−33,316 |
| Dermira, Inc. | 0 | reported | 20 Feb 2020 | tx 20+64,032−53,678 |
| Regulus Therapeutics Inc. | 0 | reported | 25 Jun 2025 | tx 18+397,250−217,475 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Oct 2025 | PURCHASE | Zenas BioPharma, Inc. | 63,158 | 19.00 USD | first after silence |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 62,500 | — | |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 30,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 9,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 4,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 2,325 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 4,650 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 60,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 15,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 30,000 | — | deriv |
| 10 Jun 2025 | GRANT_AWARD | Zenas BioPharma, Inc. | 18,500 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Regulus Therapeutics Inc. | 62,500 | 0.00 USD | |
| 16 Sept 2024 | CONVERSION | Zenas BioPharma, Inc. | 1,505,388 | — | |
| 16 Sept 2024 | CONVERSION | Zenas BioPharma, Inc. | 669,061 | — | |
| 16 Sept 2024 | PURCHASE | Zenas BioPharma, Inc. | 441,176 | 17.00 USD | |
| 16 Sept 2024 | PURCHASE | Zenas BioPharma, Inc. | 441,176 | 17.00 USD | |
| 12 Sept 2024 | GRANT_AWARD | Zenas BioPharma, Inc. | 37,000 | 0.00 USD | deriv |
| 16 Sept 2024 | CONVERSION | Zenas BioPharma, Inc. | 5,809,528 | — | deriv |
| 16 Sept 2024 | CONVERSION | Zenas BioPharma, Inc. | 13,071,439 | — | deriv |
| 13 Jun 2024 | GRANT_AWARD | TREVENA INC | 13,700 | 0.00 USD | deriv |
| 20 May 2024 | GRANT_AWARD | Regulus Therapeutics Inc. | 60,000 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | Regulus Therapeutics Inc. | 30,000 | 0.00 USD | deriv |
| 10 Aug 2023 | GRANT_AWARD | Regulus Therapeutics Inc. | 15,000 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | TREVENA INC | 13,700 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Regulus Therapeutics Inc. | 30,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 Oct 2025.